Oncology - European Medical Journal

This site is intended for healthcare professionals

Continue

Oncology

Filter
11 Mins
18 Oct 2021

Moving Towards Precision Medicine for Patients with Cholangiocarcinoma

Current diagnostic approaches in CCA are inadequate, without additional histological confirmation and, with no efficient screening…
10 Mins
13 Aug 2021

Trial Outcomes and Sub-Analyses of Direct Oral Anticoagulants in the Treatment of Cancer-Related Venous Thromboembolism: Interviews with Key Opinion Leaders

EMJ conducted interviews with two key opinion leaders and specialists in the prevention and treatment of cancer-related venous…
EMJ Oncology 9 [Supplement 3] 2021 Feature Image
10 Mins
4 May 2021

Reimagining Treatment of HR+, HER2- Early Breast Cancer

Dr Prat explained that there are three main variables that should be considered when determining the risk of recurrence for…
EMJ 6.1 Feature Image
11 Mins
23 Mar 2021

Addressing the Unmet Need in Treatment of Nonmelanoma Skin Cancers: Interviews with Two Key Opinion Leaders

Nonmelanoma skin cancers (NMSC) are a diverse group of cutaneous malignancies and are the most common forms of human neoplasia worldwide…
3 Mins
19 Feb 2021

Final Results from the ClarIDHy Phase III Study of Ivosidenib Versus Placebo in Patients with Previously Treated Cholangiocarcinoma and an Isocitrate Dehydrogenase 1 (IDH1) Mutation

Cholangiocarcinoma (CCA) is a rare cancer for which there are limited effective therapies.1,2 Mutations in the isocitrate dehydrogenase 1 gene (IDH1)…
EMJ Oncology 9 [Supplement 1] 2021 feature image
10 Mins
12 Jan 2021

Expanding Possibilities in EGFR-Mutated Advanced NSCLC: Interviews with Four Key Opinion Leaders

Worldwide, there were approximately 2.10 million patients diagnosed with, and 1.77 million deaths caused by, lung cancer in 2018. Approximately…
EMJ Oncology 8 [Supplement 4] 2020 Feature Image
6 Mins
16 Dec 2020

3rd Breast Cancer Virtual Masterclass Symposium: MONARCH 2, a Phase III Study of Abemaciclib or Placebo in Combination with Fulvestrant

More than 70% of patients diagnosed with metastatic breast cancer present with oestrogen-HR+ disease and are therefore candidates for endocrine…
EMJ Oncology 8.1 2020 Feature Image
8 Mins
5 Nov 2020

Next-Generation Sequencing Standard of Care for Molecular Profiling

Given that COVID-19 has posed unique challenges in cancer care, a number of speakers addressed, with evidence, the impact of COVID-19…
We’ve noticed you’re accessing
from North/South America.